Results: 8
Frequency and Phenotype of Human Circulating and Intrahepatic Natural Killer Cell Subsets Is Differentially Regulated according to Stage of Chronic Liver Disease.
- Published in:
- Digestion, 2013, v. 88, n. 1, p. 1, doi. 10.1159/000350821
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Digestion, 2013, v. 88, n. 1, p. X, doi. 10.1159/000354633
- Publication type:
- Article
Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-α Monoclonal Antibody Treatment for Crohn's Disease.
- Published in:
- Digestion, 2013, v. 88, n. 1, p. 17, doi. 10.1159/000351386
- By:
- Publication type:
- Article
Racial/Ethnic and Regional Differences in the Prevalence of Inflammatory Bowel Disease in the United States.
- Published in:
- Digestion, 2013, v. 88, n. 1, p. 20, doi. 10.1159/000350759
- By:
- Publication type:
- Article
Severe and Morbid Obesity in Crohn's Disease Patients: Prevalence and Disease Associations.
- Published in:
- Digestion, 2013, v. 88, n. 1, p. 26, doi. 10.1159/000351529
- By:
- Publication type:
- Article
Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection.
- Published in:
- Digestion, 2013, v. 88, n. 1, p. 33, doi. 10.1159/000350719
- By:
- Publication type:
- Article
Outcomes of Secondary Self-Expandable Metal Stents versus Surgery after Delayed Initial Palliative Stent Failure in Malignant Colorectal Obstruction.
- Published in:
- Digestion, 2013, v. 88, n. 1, p. 46, doi. 10.1159/000351208
- By:
- Publication type:
- Article
On-Demand Proton Pump Inhibitory Treatment in Overweight/Obese Patients with Gastroesophageal Reflux Disease: Are There Pharmacodynamic Arguments for Using Higher Doses?
- Published in:
- Digestion, 2013, v. 88, n. 1, p. 56, doi. 10.1159/000351389
- By:
- Publication type:
- Article